{"AllianceGenome": "7854", "HGNC": "7854", "MIM": "603525", "_id": "9111", "_version": 1, "accession": {"genomic": ["AC009311.3", "CH471058.2", "CP068276.2", "NC_000002.12", "NC_060926.1"], "protein": ["AAC12949.1", "AAH01268.1", "AAH21987.1", "AAY15066.1", "ABO65092.1", "BAF84237.1", "BAG60896.1", "BAG70119.1", "BAG70250.1", "EAX11513.1", "NP_004679.2", "Q13287.2", "XP_005246998.1", "XP_047302226.1", "XP_054200448.1", "XP_054200449.1"], "rna": ["AB451305.1", "AB451436.1", "AK124323.1", "AK291548.1", "AK298754.1", "BC001268.1", "BC021987.2", "CB151555.1", "EF036506.1", "NM_004688.3", "U32849.1", "XM_005246941.3", "XM_047446270.1", "XM_054344473.1", "XM_054344474.1"], "translation": [{"protein": "BAF84237.1", "rna": "AK291548.1"}, {"protein": "AAH01268.1", "rna": "BC001268.1"}, {"protein": "BAG70119.1", "rna": "AB451305.1"}, {"protein": "NP_004679.2", "rna": "NM_004688.3"}, {"protein": "BAG60896.1", "rna": "AK298754.1"}, {"protein": "AAC12949.1", "rna": "U32849.1"}, {"protein": "XP_005246998.1", "rna": "XM_005246941.3"}, {"protein": "ABO65092.1", "rna": "EF036506.1"}, {"protein": "BAG70250.1", "rna": "AB451436.1"}, {"protein": "XP_047302226.1", "rna": "XM_047446270.1"}, {"protein": "AAH21987.1", "rna": "BC021987.2"}, {"protein": "XP_054200448.1", "rna": "XM_054344473.1"}, {"protein": "XP_054200449.1", "rna": "XM_054344474.1"}]}, "ensembl": {"gene": "ENSG00000123609", "protein": ["ENSP00000243346", "ENSP00000387373"], "transcript": ["ENST00000243346", "ENST00000414946", "ENST00000477072", "ENST00000491771"], "translation": [{"protein": "ENSP00000243346", "rna": "ENST00000243346"}, {"protein": "ENSP00000387373", "rna": "ENST00000414946"}], "type_of_gene": "protein_coding"}, "entrezgene": "9111", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 10.7867032899, "exp_mis": 88.370224035, "exp_syn": 37.3011160782, "lof_z": -0.365942141848459, "mis_z": -1.07339130868535, "mu_lof": 7.38610339604e-07, "mu_mis": 7.84839512279e-06, "mu_syn": 3.18676982236e-06, "n_lof": 12.0, "n_mis": 109.0, "n_syn": 37.0, "p_li": 6.22629202890385e-09, "p_null": 0.930317629204001, "p_rec": 0.069682364569707, "syn_z": 0.0305652600476813}, "bp": 924, "cds_end": 152139462, "cds_start": 152127206, "n_exons": 7, "nonpsych": {"exp_lof": 9.62522185963, "exp_mis": 79.8457970836, "exp_syn": 33.6233236332, "lof_z": -0.118637186927188, "mis_z": -1.36341568280455, "mu_lof": 7.38610339604e-07, "mu_mis": 7.84839512279e-06, "mu_syn": 3.18676982236e-06, "n_lof": 10.0, "n_mis": 104.0, "n_syn": 34.0, "p_li": 2.82067615253223e-07, "p_null": 0.842749926888601, "p_rec": 0.157249791043784, "syn_z": -0.040899289192912}, "nontcga": {"exp_lof": 9.91033685119, "exp_mis": 81.2871813022, "exp_syn": 34.3035973741, "lof_z": -0.654806984538071, "mis_z": -0.70249076209098, "mu_lof": 7.38610339604e-07, "mu_mis": 7.84839512279e-06, "mu_syn": 3.18676982236e-06, "n_lof": 12.0, "n_mis": 94.0, "n_syn": 35.0, "p_li": 3.1753439246588e-09, "p_null": 0.952649066545209, "p_rec": 0.0473509302794473, "syn_z": -0.0752854791180683}, "transcript": "ENST00000243346.5"}, "exons": [{"cdsend": 151282948, "cdsstart": 151270692, "chr": "2", "position": [[151270469, 151270875], [151271625, 151271732], [151275483, 151275670], [151275757, 151275864], [151278827, 151278990], [151281947, 151282043], [151282867, 151282954], [151289592, 151289668]], "strand": -1, "transcript": "NM_004688", "txend": 151289668, "txstart": 151270469}], "exons_hg19": [{"cdsend": 152139462, "cdsstart": 152127206, "chr": "2", "position": [[152126983, 152127389], [152128139, 152128246], [152131997, 152132184], [152132271, 152132378], [152135341, 152135504], [152138461, 152138557], [152139381, 152139468], [152146106, 152146182]], "strand": -1, "transcript": "NM_004688", "txend": 152146182, "txstart": 152126983}], "generif": [{"pubmed": 11911807, "text": "Dissociation of the IFN-induced protein NMI from IFP35 is a newly defined specific cytoplasmic event occurring during apoptosis."}, {"pubmed": 11916966, "text": "complex with BRCA1 and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene promoter activity in breast cancer"}, {"pubmed": 12019454, "text": "Apoptin mutant T1 still interacted with Nmi, suggesting that its C-terminal 11 AA was not essential for the interaction."}, {"pubmed": 15996661, "text": "STAT1 and Nmi are downstream targets of Ets-1 in MCF-7 human breast cancer cells"}, {"pubmed": 16214168, "text": "identified an association of Sox10 with the N-myc interactor Nmi, which was mediated by the high-mobility group of Sox10 and the central region of Nmi; Nmi modulated the transcriptional activity of Sox10"}, {"pubmed": 17197158, "text": "The results provide a novel role of CKIP-1 in cytokine signaling response and the biochemical mechanism, by which two previously identified modulators IFP35 and Nmi are involved via interactions."}, {"pubmed": 17565738, "text": "Activation of PKCdelta in response to Camptothecin treatment requires Myc and is important in CPT-mediated apoptosis signaling."}, {"pubmed": 18794094, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18950845, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19240718, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19358268, "text": "Data suggest that overexpression of Nmi inhibits the Wnt/beta-catenin signaling via up-regulation of Dkk1 and retards tumor growth."}, {"pubmed": 20237496, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 23034180, "text": "Thus our work reveals a novel NMI-mediated, transcription-independent ARF induction pathway in response to cellular stresses."}, {"pubmed": 24936061, "text": "identified NMI induction as a novel negative feedback mechanism that decreases IRE1alpha-dependent activation of JNK and apoptosis in cytokine-exposed beta cells"}, {"pubmed": 25174825, "text": "Results show that aberrant miR-29 expression may account for reduced NMI expression in breast tumors and mesenchymal phenotype of cancer cells that promotes invasive growth."}, {"pubmed": 25387807, "text": "Its potential function in transcriptional activation of NMI."}, {"pubmed": 25669971, "text": "overexpression or depletion of NMI revealed its regulation on G1/S progression and cell proliferation (both in vitro and in vivo), and this effect was partially dependent on STAT1, which interacted with and was regulated by NMI."}, {"pubmed": 25907116, "text": "The results showed that SARS coronavirus protein 6 can promote the ubiquitin-dependent proteosomal degradation of Nmi."}, {"pubmed": 26146406, "text": "N-myc and STAT interactor sensitizes breast cancer cells to cisplatin treatment through DRAM1 dependent autophagy."}, {"pubmed": 26342464, "text": "Trim21 regulates Nmi-IFI35 complex-mediated inhibition of innate antiviral response"}, {"pubmed": 27012186, "text": "N-Myc-interacting protein (NMI) negatively regulates epithelial-mesenchymal transition by inhibiting the acetylation of NF-kappaB/p65 in histone deacetylase-dependent manner."}, {"pubmed": 28077802, "text": "Data suggest that N-myc (and STAT) interactor (NMI) could improve its downstream target bradykinin B2 receptor (BDKRB2) expression to induce extracellular signal-regulated kinases (ERK) 1/2 activation, and thereby further evoke malignant progression of hepatocellular carcinoma (HCC)."}, {"pubmed": 28492540, "text": "results provide new insights into understanding the regulatory mechanism of cancer stem cells and suggest that the NMI-YY1-hTERT signaling axis may be a potential therapeutic target for breast cancers."}, {"pubmed": 28913576, "text": "These results revealed that IRF-1 is involved in the IFN-inducible expression of Nmi."}, {"pubmed": 29025423, "text": "Our study showed that NMI suppressed tumor growth by inhibiting PI3K/AKT, MMP2/MMP9, COX-2/PGE2 signaling pathways and p300-mediated NF-kappaB acetylation, and predicted a favorable prognosis in human lung adenocarcinomas, suggesting that NMI was a potential tumor suppressor in lung cancer."}, {"pubmed": 29030066, "text": "These investigations demonstrated etoposide-induced NMI can suppress tumor proliferation and promote cell apoptosis by activating the ARF-p53 signaling pathway in lung carcinoma. Our results provide an alternative mechanism for etoposide in lung carcinoma and suggest NMI has a critical role in suppressing lung carcinoma progression."}, {"pubmed": 29038465, "text": "Damage-associated molecular patterns (DAMP) are important mediators of innate immunity. Here the authors show that N-myc and STAT interactor (NMI) and interferon-induced protein 35 (IFP35) act as DAMPs to promote inflammation by activating macrophages via the Toll-like receptor 4 and NF-kappaB pathways."}, {"pubmed": 29109532, "text": "Negatively Regulates TNF-alpha-Induced NF-kappaB Transcriptional Activity by Sequestering NF-kappaB/p65 in the Cytoplasm"}, {"pubmed": 29326438, "text": "Nmi has a distinct role in the differentiation process of mammary luminal epithelial cell compartment and developmental aberrations resulting from Nmi absence contribute to metastasis."}, {"pubmed": 29859005, "text": "NMI and RAC1 might represent two new key genes related to gastric cancer"}, {"pubmed": 30771232, "text": "Elevated serum NMI (>/= 198.5 pg/mL) was correlated with poor survival rate of acute-on-chronic liver failure of hepatitis B virus patients."}, {"pubmed": 31230364, "text": "NMI promotes cell proliferation through TGFbeta/Smad pathway by upregulating STAT1 in colorectal cancer."}, {"pubmed": 33781665, "text": "N-myc-interactor mediates microbiome induced epithelial to mesenchymal transition and is associated with chronic lung allograft dysfunction."}, {"pubmed": 34362845, "text": "IFP35 family proteins promote neuroinflammation and multiple sclerosis."}, {"pubmed": 37846815, "text": "NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3-IFIT3 axis."}], "genomic_pos": {"chr": "2", "end": 151289894, "ensemblgene": "ENSG00000123609", "start": 151270470, "strand": -1}, "genomic_pos_hg19": {"chr": "2", "end": 152146571, "start": 152126979, "strand": -1}, "go": {"BP": [{"evidence": "IDA", "gocategory": "BP", "id": "GO:0002281", "pubmed": 29038465, "qualifier": "involved_in", "term": "macrophage activation involved in immune response"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007259", "pubmed": 10597290, "qualifier": "involved_in", "term": "cell surface receptor signaling pathway via JAK-STAT"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0008285", "pubmed": 29350881, "qualifier": "involved_in", "term": "negative regulation of cell population proliferation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0009615", "qualifier": "involved_in", "term": "response to virus"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032687", "qualifier": "involved_in", "term": "negative regulation of interferon-alpha production"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032688", "qualifier": "involved_in", "term": "negative regulation of interferon-beta production"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0034142", "qualifier": "involved_in", "term": "toll-like receptor 4 signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045087", "qualifier": "involved_in", "term": "innate immune response"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045089", "qualifier": "involved_in", "term": "positive regulation of innate immune response"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045824", "pubmed": 26342464, "qualifier": "involved_in", "term": "negative regulation of innate immune response"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0050729", "qualifier": "involved_in", "term": "positive regulation of inflammatory response"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0070936", "qualifier": "involved_in", "term": "protein K48-linked ubiquitination"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1901223", "pubmed": 29350881, "qualifier": "involved_in", "term": "negative regulation of non-canonical NF-kappaB signal transduction"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1901224", "pubmed": 29038465, "qualifier": "involved_in", "term": "positive regulation of non-canonical NF-kappaB signal transduction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1902524", "qualifier": "involved_in", "term": "positive regulation of protein K48-linked ubiquitination"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005615", "pubmed": 29038465, "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": [9781816, 10950963], "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": [9781816, 10597290, 10950963], "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "pubmed": [10779520, 10950963], "qualifier": "located_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016020", "pubmed": 10950963, "qualifier": "located_in", "term": "membrane"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [9989503, 10597290, 10779520, 10950963, 16189514, 16214168, 16919237, 20211142, 21516116, 25416956, 26342464, 26871637, 27107012, 28514442, 31515488, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": [21516116, 25416956, 32296183], "qualifier": "enables", "term": "identical protein binding"}]}, "homologene": {"genes": [[7955, 792676], [8364, 613094], [9031, 424314], [9544, 694554], [9598, 470714], [9606, 9111], [9615, 476146], [9913, 511280], [10090, 64685], [10116, 311021]], "id": 3441}, "interpro": [{"desc": "Nmi/IFP 35 domain", "id": "IPR009909", "short_desc": "Nmi/IFP35_dom"}, {"desc": "Nmi/IFP 35 domain, N-terminal", "id": "IPR009938", "short_desc": "Nmi/IFP35_N"}, {"desc": "Nucleotide-binding alpha-beta plait domain superfamily", "id": "IPR012677", "short_desc": "Nucleotide-bd_a/b_plait_sf"}], "ipi": ["IPI00012450", "IPI00917177"], "map_location": "2q23.3", "name": "N-myc and STAT interactor", "other_names": "N-myc-interactor", "pantherdb": {"HGNC": "7854", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1928368", "ortholog_type": "LDO", "panther_family": "PTHR15225", "taxid": 10090, "uniprot_kb": "O35309"}, {"Ensembl": "ENSGALG00000012480", "ortholog_type": "LDO", "panther_family": "PTHR15225", "taxid": 9031, "uniprot_kb": "A0A1L1RUW5"}], "uniprot_kb": "Q13287"}, "pathway": {"biocarta": [{"id": "il2rbpathway", "name": "il-2 receptor beta chain in t cell activation"}, {"id": "il7pathway", "name": "il-7 signal transduction"}], "netpath": {"id": "Pathway_IL2", "name": "IL2"}, "reactome": [{"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-5663205", "name": "Infectious disease"}, {"id": "R-HSA-9678108", "name": "SARS-CoV-1 Infection"}, {"id": "R-HSA-9679506", "name": "SARS-CoV Infections"}, {"id": "R-HSA-9692914", "name": "SARS-CoV-1-host interactions"}, {"id": "R-HSA-9692916", "name": "SARS-CoV-1 activates/modulates innate immune responses"}, {"id": "R-HSA-9824446", "name": "Viral Infection Pathways"}], "wikipathways": {"id": "WP49", "name": "IL-2 signaling pathway"}}, "pfam": ["PF07292", "PF07334"], "pharmgkb": "PA31659", "pharos": {"target_id": 18489, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF259655", "relationship": "is"}, {"id": "GNF259656", "relationship": "is"}, {"id": "GNF259657", "relationship": "is"}, {"id": "GNF259658", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": [{"id": "GNF157302", "relationship": "is"}, {"id": "GNF161599", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF010385", "relationship": "is"}, {"id": "GNF010386", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": {"id": "GNF236729", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF113943", "relationship": "is"}, {"id": "GNF153584", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000002.12", "NC_060926.1"], "protein": ["NP_004679.2", "XP_005246998.1", "XP_047302226.1", "XP_054200448.1", "XP_054200449.1"], "rna": ["NM_004688.3", "XM_005246941.3", "XM_047446270.1", "XM_054344473.1", "XM_054344474.1"], "translation": [{"protein": "NP_004679.2", "rna": "NM_004688.3"}, {"protein": "XP_005246998.1", "rna": "XM_005246941.3"}, {"protein": "XP_047302226.1", "rna": "XM_047446270.1"}, {"protein": "XP_054200449.1", "rna": "XM_054344474.1"}, {"protein": "XP_054200448.1", "rna": "XM_054344473.1"}]}, "reporter": {"HG-U133_Plus_2": "203964_at", "HG-U95Av2": "36472_at", "HTA-2_0": "TC02002425.hg.1", "HuEx-1_0": ["2580955", "3471745"], "HuGene-1_1": "8055702", "HuGene-2_1": "16903537"}, "summary": "NMYC interactor (NMI) encodes a protein that interacts with NMYC and CMYC (two members of the oncogene Myc family), and other transcription factors containing a Zip, HLH, or HLH-Zip motif. The NMI protein also interacts with all STATs except STAT2 and augments STAT-mediated transcription in response to cytokines IL2 and IFN-gamma. The NMI mRNA has low expression levels in all human fetal and adult tissues tested except brain and has high expression in cancer cell line-myeloid leukemias. [provided by RefSeq, Jul 2008].", "symbol": "NMI", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1334885"}, "unigene": "Hs.54483", "uniprot": {"Swiss-Prot": "Q13287", "TrEMBL": "C9JW17"}, "wikipedia": {"url_stub": "N-myc-interactor"}}